Dexcom G5 Mobile CGM system clears the FDA
This is the first and only full mobile CGM system that allows adults and children as young as 2 years old to conveniently monitor and share glucose levels.
LA Dodgers Accelerator launches with 10 startups, 2 digital health focused
The LA-based program lasts three months and will help startups that are focused on the intersection of sports, technology, entertainment, and media.
Sales of connected digital fitness trackers to exceed 82 million units in 2019
Weight scale, blood pressure monitor, glucometer, pulse oximeter for OTC use, and insulin pump will generate total U.S. sales of nearly 17M units in 2019.
HealthWatch’s MasterCaution Device gets CE approval
The device can function as an ECG machine, event recorder, long-term Holter monitor, and remote telemetry device -- all in a single miniature package.
Zephyr Health raises $17.5M Series C in a round led by Google Ventures
The company's solution provides predictive insights that enable customers to accelerate time to market for drugs, diagnostics and devices.
Capital BlueCross launching Amwell-powered telehealth service in 2016
Beginning Jan. 1, 2016, customers will be able to use a computer, tablet or smartphone - to log on for telehealth appointments any time of day.
Gauss Surgical raises $3.3M for an app that estimates blood loss during surgeries
The FDA-cleared Triton Canister app for iPad enables the user to take pictures of the surgical canisters, and return the information within just a few seconds.
Xerox acquiring RSA Medical to advance its population health offering
RSA Medical will help Xerox's Commercial Healthcare Services business expand to support healthcare payers throughout all stages of member engagement.
Bayer’s Grants4Apps 2015 accelerator launches with 5 startups
The pharmaceuticals giant selected the five companies from more than 200 applications from 48 countries to participate in this year's Grants4Apps program.
SkinVision secures $3.4M for its skin cancer checker app
The company will use the funds to widen applications for its technology beyond moles and melanomas, and expand into new geographical markets.








